|
Michael R. Knapp is a trained scientist and successful entrepreneur. Prior to joining Cambrios, Dr. Knapp co-founded Caliper Life Sciences (Nasdaq: CALP), then Caliper Technologies, and played an integral role in the creation and development of the company. As the Vice President of Corporate Development, he configured the company's technology access program and drove the establishment of partnerships with a number pharmaceutical and biotechnology companies. He also created the Applications Developer Program that enabled other companies, in different fields, to apply Caliper's microfluidic technology to their unique analytical needs. Dr. Knapp also co-founded Amphora Discovery Corp., a chemical genomics company that was formed from within Caliper with independent funding and management. Before starting Caliper, Dr. Knapp served as President and Scientific Director at Molecular Tool, Inc., a genetics technology company that he co-founded. Dr. Knapp also served on the staff of the Center for Neurobiology and Behavior at Columbia University and was Scientific Director of Genetica SARL, an affiliate of Rhone Poulenc SA in Paris, France. Dr. Knapp holds a B.S. in Biology from Trinity College (Hartford) and a Ph.D. in Medical Microbiology from Stanford University. | 